N-95 Mask Market, By Valve (With Exhalation Valve and Mask Without Exhalation Valve), By Usage (Disposable and Reusable), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Specialty Drug Stores, Online Stores, Others), By End User (Hospitals & Clinical, Ambulatory Surgery Centers, Research Institutes, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

N-95 Mask Market Accounted For US$ 1.5 Billion In 2020 And Is Estimated To Be 40.4 Billion By 2029 And Is Anticipated To Register A Cagr Of 43.8%.

N95 Mask is a respiratory protective device manufactured to gain a very close facial fit and very effective filtration of airborne particles. The N95 respirators when exposed to testing are predicted to block at least 95% of 0.3 micron particles, therefore called as N95 respirators. These N95 Respirators are not oil proof. National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), and Occupational Safety and Health Administration (OSHA) also regulate N95 respirators.

In order to address increasing demand of masks during the coronavirus outbreak i.e. COVID-19, several key players are increasing their production and making millions of N95 masks. Additionally, with an upsurge of these diseases globally, the N-95 masks market has been flourish in such a way that the mask markers have to manufacture masks in numerous numbers and improve their market position. For instance, Honeywell is rapidly ramping up production and making millions of the N95 masks in the U.S. They are expanding manufacturing operations in a factory in Rhode Island, Smithfield, which also produces UVEX safety glasses. This respiratory mask is manufactured for use for particles such as those from sanding, grinding, sweeping, bagging, sawing, or other dusty operations. This respiratory mask can also aid to decrease inhalation exposures to specific airborne biological particles (examples: Mold, bacillus anthracis, mycobacterium tuberculosis), but does not eradicate the risk of contracting illness, infection, or disease. This particulate respirator is approved by NIOSH (National Institute for Occupational Safety and Health) for environments covering certain non-oil based particles and offers at least 95 % filter efficiency. However, people suffering from chronic respiratory, cardiac, or other medical conditions should contact their health care provider before using an N95 respirator because the N95 respirator may cause more difficulty in breathing for patients.

Market Trend

• Adoption of different kinds of filters in these N95 masks
• Adoption of light-weighted mask

Opportunities

• With the growing number of affected humans globally majorly in china
• Increasing demand for full cure of coronavirus disease

The global N-95 mask market is segmented based on valve, usage, distribution channel, end-user, and region.

On the basis of valve, the global N-95 mask market is segmented into with exhalation valve and mask without exhalation valve. Based on usage, the target market is segmented into disposable and reusable. Based on distribution channel, the target market is segmented into retail pharmacies, hospital pharmacies, specialty drug stores, online stores, and others. Based on end-user, the target market is segmented into hospitals & clinical, ambulatory surgery centers, research institutes, and other end users.

Regional Insights:

On region the global N-95 mask market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. China’s daily production was about 20 million units. It used to produce about more than half of the world’s mask production. In December 2019, ever since the pandemic broke out first in China, there had been temporary shutdown of the factories causing disrupt in production of these masks. Now, that factories are commencing slowly they are finding it hard to meet even the local demands and are not able to respond to global orders. U.S ranks second for the production of N-95 masks in the world. However, due to pandemic they has been shortage of the masks to meet the growing demands in the region. They have almost only 1% of required masks needed to fight the outbreak. They are planning to buy 500 million masks for the nation stockpile and has requested Prestige Ameritech highest U.S. surgical mask manufacturer to supply 1.5 billion masks. Whereas, 3M factories in South Dakota and Nebraska are producing 35 million N95 masks a month and 90% of them are given to the healthcare workers. Honeywell is looking for US$5 billion term loan to expand the N95 mask production. In Europe, Italy is the worst affected European country due to COVID-19. It had a requirement of 90 million masks monthly. Germany is the third widest affected European country. Daimler Group Automakers and Volkswagen have agreed to provide over 300,000 masks to health authorities that was available at their stockpile.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest application trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global N-95 mask market report based on valve, usage, distribution channel, end-user, and region.

Global N-95 Mask Market, By Valve:

• With Exhalation Valve
• Mask without Exhalation Valve

Global N-95 Mask Market, By Usage:

• Disposable
• Reusable

Global N-95 Mask Market, By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Specialty Drug Stores
• Online Stores
• Others

Global N-95 Mask Market, By End-user:

• Hospitals & Clinical
• Ambulatory Surgery Centers
• Research Institutes
• Other End Users

Global N-95 Mask Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the global N-95 mask market includes 3M, Honeywell, Prestige Ameritech, Kimberly-Clark, Shanghai Dasheng, Vogmask, Cambridge Mask Co, DACH Schutzbekleidung GmbH & Co. KG, Te Yin, KOWA, Gerson, Hakugen, and Cardinal Health. The outbreak has resulted to rigorous and constant working of several companies towards mass production of N95 and surgical masks. 3M and Honeywell multinational conglomerate companies are leading the production in the U.S and other regions worldwide. Prestige Ameritech limited supplying mask production to countries globally. Te Yin and Shanghai Dasheng are some of the respirator producers from China. Cambridge Mask Co (UK) and DACH Schutzbekleidung GmbH (Germany) are some of the European mask manufacturers.

• 3M
  • Company Overview
  • Valve Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Honeywell
• Prestige Ameritech
• Kimberly-Clark
• Shanghai Dasheng
• Vogmask
• Cambridge Mask Co.
• DACH Schutzbekleidung GmbH & Co. KG
• Te Yin
• KOWA
• Gerson
• Hakugen
• Cardinal Health

“*” marked represents similar segmentation in other categories in the respective section